Minireviews
Copyright ©The Author(s) 2024.
World J Transplant. Mar 18, 2024; 14(1): 87532
Published online Mar 18, 2024. doi: 10.5500/wjt.v14.i1.87532
Figure 6
Figure 6 Comparison of progression free survival and overall survival between full dose melphalan (MEL) (200 mg/m2), low or reduced intensity MEL (100 mg/m2), and modified MEL (100 mg/m2). PFS: Progression free survival; OS: Over survival; MEL: Melphalan.